The pharmaceutical vial capping process: Container closure systems, capping equipment, regulatory framework, and seal...

Area of Science:

• Pharmaceutical Sciences
• Packaging Engineering
• Quality Control

Background:

• Parenteral drug products require primary packaging for microbial protection.
• The common container closure system (CCS) involves glass vials, rubber stoppers, and aluminum crimp caps.
• A well-characterized capping process is crucial for product quality and minimizing manufacturing rejections.

Purpose of the Study:

• To summarize health authority requirements for container closure system quality and integrity.
• To describe pharmaceutical vials, rubber stoppers, and crimp caps.
• To critically compare different vial capping techniques and analyze cosmetic defects.

Main Methods:

• Review of health authority guidelines and scientific literature.
• Description and comparison of pharmaceutical vial, stopper, and cap components.
• Analysis of various capping techniques, including particle generation.
• Evaluation of methods for capping process control, such as residual seal force.

Main Results:

• The rotating capping plate method generates the fewest particles.
• The residual seal force method offers equipment-independent characterization of the capping process.
• Root causes of cosmetic defects in vial capping are analyzed.

Conclusions:

• Optimizing vial capping processes is essential for ensuring parenteral drug product integrity.
• Understanding capping techniques and control methods like residual seal force is key to pharmaceutical quality.
• Addressing cosmetic defects improves manufacturing efficiency and product acceptance.